Galactoside-specific misletoe lectin modulates dexamethasone-induced apoptosis and glucocorticoid receptor level in Balb/c thymocytes

In Vivo

Volumn 17, Issue 2, 2003, Pages 163-167

  Hajto T ^a   Berki, Timea ^a   Palinkas L ^a   Boldizsar F ^a   Nagy, G ^a   Nemeth P ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Apoptosis; Glucocorticoid receptor; Misletoe lectin

Indexed keywords

DEXAMETHASONE; DNA; FLUORESCEIN ISOTHIOCYANATE; GALACTOSIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; LIPOCORTIN 5; PLACEBO; PLANT LECTIN; PROPIDIUM IODIDE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; FLOW CYTOMETRY; FLUORESCENCE; IMMUNOBIOLOGY; IMMUNOREACTIVITY; IN VIVO STUDY; LEUKOCYTE COUNT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STAINING; THYMOCYTE; VISCUM ALBUM;

EID: 0038180328     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fryer CJ, Kinyamu HK, Rogatsky I, Garabedian MJ and Archer TK: Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J Biol Chem 275: 17771-17777, 2000.
2. Morand E: Corticosteroids in the treatment of rheumatologic diseases. Curr Opin Rheumatol 9: 200-205, 1997.
3. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR and Balow JE: Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 119: 1198-1208, 1993.
4. Surh CD and Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372: 100-103, 1994.
5. Jameson SC and Bevan M: T-cell selection. Curr Opin Immunol 10: 214-227, 1998.
6. Pazirandeh A, Xue Y, Rafter I, Sjövall J, Jondal M and Okret S: Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J 13: 893-900, 1999.
7. Vacchio MS, Ashwell JD and King LB: A positive role for thymus-derived steroids in formation of the T-cell repertoire. Ann NY Acad Sci 840: 317-27, 1998.
8. Baus E, Andris F, Dubois PM, Urbain J and Leo O: Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J Immunol 156: 4555-4561, 1996.
9. Berki T, Pálinkás L, Boldizsár F and Németh P: Glucocorticoid (GC) sensitivity and GC receptor expression differ in thymocyte subpopulations. Int Immunol 14: 463-469, 2002.
10. Ashwell JD, Lu FW and Vacchio MS: Glucocorticoids in T cell development and function. Annu Rev Immunol 18: 309-45, 2000.
11. Purton JF, Boyd RL, Cole TJ and Godfrey DI: Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13: 179-86, 2000.
12. Miller AH, Spencer RL, Pearce BD, Pisell TL, Azrieli Y, Tanapat P, Moday H, Rhee R and McEwen BS: Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system. Cell Immunol 186: 45-54, 1998.
13. Hajto T, Berki T, Boldizsár G and Németh P: Galactoside-specific plant lectin, Viscum album agglutinin-I induces enhanced proliferation and apoptosis of murine thymocytes in vivo. Immunol Letters (in press), 2002.
14. Hajto T, Hostanska K and Gabius H-J: Modulatory potency of the β-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 49: 4803-8, 1989.
15. Berki T, Kumanovics G, Kumanovics A, Falus A, Ujhelyi E and Németh P: Production and flow-cytometric application of a monoclonal anti-glucocorticoid receptor antibody. J Immunol Methods 214: 19-27, 1998.
16. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C: A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled Annexin V. J Immunol Methods 184: 39-46, 1995.
17. Reichardt HM, Umland T, Bauer A, Kretz O and Schutz G: Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol Cell Biol 20: 9009-17, 2000.
18. R) Dtsch Zschr Onkol 23: 1-6, 1991.
19. Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H and Saller R: Effect of a recombinant lectin, Viscum album agglutinin (rVAA) on secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK cell-mediated cytotoxicity of rat splenocytes in vitro and in in vivo. Nat Immun 16: 34-46, 1998.
20. Pazirandeh A, Xue Y, Prestegaard T, Jondal M and Okret S: Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J 16: 727-9, 2002.
21. Mengs U, Göthel D and Leng-Peschlow E: Mistletoe extracts standardized to mistletoe lectins in oncology: Review on current status of preclinical research. Anticancer Res 22: 1399-1408, 2002.
22. Heiny BM and Beuth J: Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 14: 1339-1342, 1994.
23. Heiny BM, Albrecht V and Beuth J: Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract. Anticancer Res 18: 583-6, 1998.
24. Beuth J, Ko HL, Gabius H-J and Pulverer G: Influence of treatment with the immuno-modulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model system. In Vivo 5: 29-32, 1991.